Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study

Matsubara, Nobuaki; Chi, Kim; ÖZGÜROĞLU, Mustafa; Rodriguez-Antolin, Alfredo; Feyerabend, Susan; Fein, Luis; Alekseev, Boris; Sulur, Giri; Protheroe, Andrew; Li, Susan; Mundle, Suneel; De Porre, Peter; Tran, Namphuong; Fizazi, Karim

doi:10.1016/j.eururo.2019.11.021

Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study

Matsubara N., Chi K. N., ÖZGÜROĞLU M., Rodriguez-Antolin A., Feyerabend S., Fein L., ...More

EUROPEAN UROLOGY, vol.77, no.4, pp.494-500, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 77 Issue: 4
Publication Date: 2020
Doi Number: 10.1016/j.eururo.2019.11.021
Journal Name: EUROPEAN UROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, EMBASE, Gender Studies Database, MEDLINE
Page Numbers: pp.494-500
Istanbul University Affiliated: No

Abstract

Background: LATITUDE, a randomized, double-blind trial, compared abiraterone acetate and prednisone (AAP) + androgen deprivation therapy (ADT) versus placebo (PBO) + ADT in high-risk metastatic castration-sensitive prostate cancer (mCSPC).